News Guest User 3/21/25 Guest User 3/21/25 Gateway Biotechnology Publishes an Article in the Journal of the Association for Research in Otolaryngology Read More Guest User 2/28/25 Guest User 2/28/25 Gateway Biotechnology Presents at ARO 2025 Read More Guest User 10/1/24 Guest User 10/1/24 Hearing Loss in the Unoperated Ear After High-Speed Drilling in Otologic and Skull Base Surgery Read More Guest User 8/22/24 Guest User 8/22/24 CEO Bao Presents at the 4th Annual Inner Ear Disorders Therapeutics Summit in Boston, MA Read More Guest User 8/21/24 Guest User 8/21/24 COO Brutnell presents at the 4th Annual Inner Ear Disorders Therapeutics Summit in Boston, MA Read More Guest User 1/3/23 Guest User 1/3/23 Gateway Biotechnology announces the successful completion of a pre-IND meeting with the FDA for GW-TT2, a novel intranasal formulation to treat tinnitus. Read More
Guest User 3/21/25 Guest User 3/21/25 Gateway Biotechnology Publishes an Article in the Journal of the Association for Research in Otolaryngology Read More
Guest User 10/1/24 Guest User 10/1/24 Hearing Loss in the Unoperated Ear After High-Speed Drilling in Otologic and Skull Base Surgery Read More
Guest User 8/22/24 Guest User 8/22/24 CEO Bao Presents at the 4th Annual Inner Ear Disorders Therapeutics Summit in Boston, MA Read More
Guest User 8/21/24 Guest User 8/21/24 COO Brutnell presents at the 4th Annual Inner Ear Disorders Therapeutics Summit in Boston, MA Read More
Guest User 1/3/23 Guest User 1/3/23 Gateway Biotechnology announces the successful completion of a pre-IND meeting with the FDA for GW-TT2, a novel intranasal formulation to treat tinnitus. Read More
